Pfizer Inc. [NYSE: PFE] closed the trading session at $30.43.
The stocks have a year to date performance of 5.70 percent and weekly performance of -1.10 percent. The stock has been moved at 11.51 percent over the last six months. The stock has performed 9.86 percent around the most recent 30 days and changed 9.86 percent over the most recent 3-months.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
If compared to the average trading volume of 36.71M shares, PFE reached to a volume of 42181682 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here’s what leading stock market gurus have to say about Pfizer Inc. [PFE]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for PFE shares is $33.85 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on PFE stock is a recommendation set at 2.25. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Argus have made an estimate for Pfizer Inc. shares, keeping their opinion on the stock as Hold, with their previous recommendation back on March 22, 2024. While these analysts kept the previous recommendation, Guggenheim raised their target price to Buy. The new note on the price target was released on February 23, 2024, representing the official price target for Pfizer Inc. stock. Previously, the target price had yet another raise to $32, while TD Cowen analysts kept a Market Perform rating on PFE stock. On October 20, 2023, analysts decreased their price target for PFE shares from 36 to 34.
The Average True Range (ATR) for Pfizer Inc. is set at 0.80, with the Price to Sales ratio for PFE stock in the period of the last 12 months amounting to 3.10. The Price to Book ratio for the last quarter was 1.87, with the Price to Cash per share for the same quarter was set at 2.10. Price to Free Cash Flow for PFE in the course of the last twelve months was 33.77 with Quick ratio for the last quarter at 0.78.
PFE stock trade performance evaluation
Pfizer Inc. [PFE] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -1.10. With this latest performance, PFE shares gained by 9.86% in over the last four-week period, additionally plugging by 11.51% over the last 6 months – not to mention a drop of -13.92% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for PFE stock in for the last two-week period is set at 59.58, with the RSI for the last a single of trading hit 57.93, and the three-weeks RSI is set at 59.28 for Pfizer Inc. [PFE]. The present Moving Average for the last 50 days of trading for this stock 28.79, while it was recorded at 30.75 for the last single week of trading, and 28.36 for the last 200 days.
Pfizer Inc. [PFE]: An insightful look at the core fundamentals
Pfizer Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.78 and a Current Ratio set at 1.05.
Earnings per share (EPS) analysis for Pfizer Inc. [PFE] stock
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for PFE. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Pfizer Inc. go to 18.40%.
Pfizer Inc. [PFE]: Institutional Ownership
There are presently around $127.81 billion, or None% of PFE stock, in the hands of institutional investors. The top three institutional holders of PFE stocks are: VANGUARD GROUP INC with ownership of 1.32 billion shares, which is approximately 8.5034%. BLACKROCK INC., holding 1.04 billion shares of the stock with an approximate value of $178.43 billion in PFE stocks shares; and BERKSHIRE HATHAWAY INC, currently with $135.36 billion in PFE stock with ownership which is approximately 5.1238%.
